BriaCell Therapeutics Corp.

TSX:BCT.TO

Biotechnology

Healthcare
$5.75 +18.88%

+$0.94 today

Market cap
$50.02M
Beta
1.53
P/E (TTM)
-0.3
EPS (TTM)
-$4.23
52W Low $3.68High $20.40

Volume 0.00M

Average 0.01M

BCT.TO Retained Earnings

Cumulative profits kept in the business rather than paid out as dividends.

BriaCell Therapeutics Corp.TSX: BCT.TO

Retained Earnings · Q3 FY2026 · quarter ended Apr 2026

Retained earnings remains negative

Q3 FY2026 retained earnings was -$134.34M, compared with -$103.66M a year earlier.

Context

  • Retained earnings amounted to 496.2% of total assets at the end of Q3 FY2026, down 113.5 pp from a year earlier.
  • Retained earnings grew in size in 3 of the last 3 fiscal years.
  • FY2025 was the largest annual figure in the 4 fiscal years shown.

What to watch

Whether retained earnings keeps falling in the next quarterly balance sheet after a -29.6% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterApr 2026
-$134.34M-5.6% QoQ
Last fiscal yearJul 2025
-$112.14M-31.2% YoY
Year agoApr 2025
-$103.66M-29.6% since
Retained Earnings past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-29.6%——
1 year-31.2%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Retained Earnings history

USD · from the balance sheet

Latest · FY2025
(112.14M) USD
Year-over-year change
-31.2%

Retained Earnings vs competitors

How BCT.TO compares with its peers on the latest reported figures

No competitor Retained Earnings figures are available to compare.

Balance Sheet

USD
Metric
FY2021
Jul 2021
FY2022
Jul 2022
FY2023
Jul 2023
FY2024
Jul 2024
FY2025
Jul 2025
Cash & Equivalents57.27M41.04M21.25M862.09K10.53M
Short-term Investments00007.4M
Net Receivables12.57K24.1K717.74K1.37M566.73K
Inventory00000
Other Current Assets00000
Total Current Assets57.8M42.35M26.95M3.65M19.99M
Property, Plant & Equipment (Net)000388.18K297.84K
Goodwill00000
Intangible Assets245.61K230.34K215.07K199.8K185.16K
Long-term Investments000418.49K526.07K
Tax Assets00000
Other Non-current Assets0001.21M719.97K
Total Non-current Assets245.61K230.34K215.07K2.22M1.73M
Total Assets58.04M42.58M27.16M5.87M21.72M
Account Payables214.12K463.28K1.12M7.17M3.29M
Short-term Debt00000
Tax Payables00000
Deferred Revenue00000
Other Current Liabilities0000696.66K
Total Current Liabilities556.8K941.09K1.8M7.46M3.99M
Long-term Debt25.99K0000
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities29.79M31.31M29.14M1.1M338.83K
Total Non-current Liabilities29.82M31.31M29.14M1.1M338.83K
Total Liabilities30.37M32.25M30.94M8.56M4.33M
Common Stock54.77M65.59M69.59M72.17M102.09M
Retained Earnings(29.14M)(60.35M)(80.65M)(85.44M)(112.14M)
Accumulated OCI(138.68K)(138.68K)(138.68K)(138.68K)27.99M
Other Stockholders Equity00011.03M0
Minority Interest000(302.52K)(548.67K)
Total Equity27.67M10.33M(3.78M)(2.68M)17.39M
Total Debt25.99K0000
Net Debt(57.24M)(41.04M)(21.25M)(862.09K)(10.53M)

BriaCell Therapeutics Corp.

TSX:BCT.TO

Intrinsic Alpha fair value

Locked

Current Price

$5.75

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.